title: In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
abstract: Based on this meta-analysis of primarily observational data, complete revascularization (CR) is associated with a reduced risk of death, MI, and repeat revascularization in patients with multivessel coronary artery disease (MVCAD) as compared with incomplete revascularization (IR). Given the current state of evidence, the likelihood of achieving complete revascularization should influence whether PCI or CABG is the best strategy in patients with MVCAD. Given the lack of randomized trials in this area, more robust trial data will address the validity of these findings.
authors.affiliation: Lahey Hospital and Medical Center, Burlington, Massachusetts.
authors.forename: Vigyan V
authors.initials: VV
authors.lastname: Bang
authors.affiliation: Lahey Hospital and Medical Center, Burlington, Massachusetts.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Levy
mesh_terms: D006801:Humans; D003324:Coronary Artery Disease / Q000601:surgery; D009204:Myocardial Revascularization / Q000592:standards; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic